NCT02940769

Neurobiological Effects of Light on MDD

Terminated NA Last updated 22 December 2022

What this trial tests

NA trial testing light glasses in Major Depressive Disorder in 7 participants. Terminated before completion.

Timeline

4 September 2014

Primary endpoint
14 February 2017

14 February 2017

Quick facts

Lead sponsor	University of Michigan
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	basic science
Enrollment	7
Start date	4 September 2014
Primary completion	14 February 2017
Estimated completion	14 February 2017
Sites	1 location across United States

Drugs / interventions tested

• light glasses
• sham glasses (placebo)

Conditions studied

• Major Depressive Disorder — all drugs for Major Depressive Disorder →

Sponsor

University of Michigan

Who can join

Adults 18 to 60, any sex, with Major Depressive Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary study objective is to observe/measure the circadian pattern of sleep, Cortisol and Melatonin in MDD subjects and Control subjects. We will also assess if controlled exposure to light in MDD subjects (post-partum females, non- post-partum females and males) will change these parameters using light glasses. In addition to the biological outcome measures (sleep, cortisol and melatonin) we will also monitor sleep and depressive symptoms in the research subjects for the duration of the protocol.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.